[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Composite Interceptive Med Science\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100324415",false,"NCT03503708","Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease","Antioxidant for Improvement of Hepatic Function in Patients With Alcohol Liver Disease Without Cirrhosis: Non-randomized Interventional Cohort Study","Inclusion Criteria:\n\nAdults aged over 18 years with the evidence of alcoholic liver disease (ALD) based on a thorough history, physical examination, and laboratory tests and all of the following:\n\n* Chronic alcohol intake, Identified with AUDIT(Alcohol Use Disorder Inventory Test) Questionnaire\n* Active alcohol use until 4 weeks prior to presentation\n* ALT and AST elevated \\>1.5 times the upper limit of normal\n* Over 1.5 ratio of AST to ALT\n* Maddrey Discriminant function(DF) less than 30\n\nExclusion Criteria:\n\n* Severe alcoholic hepatitis with cirrhosis or life expectancy less than 3 months\n* Severe renal impairment (Glomerular filtration rate below 60 ml\u002Fmin per 1.73m2)\n* Hepatic disorders due to cardiac causes, inherited metabolic causes, hemochromatosis and Wilson's disease\n* Participants with active viral hepatitis\n* Under going active treatment for alcohol withdrawal syndrome(AWS) at the study entry\n* Participants on hepatotoxic medications like antitubercular medication, antiviral medication, paracetamol etc.\n* Pregnant, attempting to conceive, or lactating women\n* Participating in another clinical trial with an active intervention or drug or device with last dose taken within 60 days.","ALL","18 Years",{"count":18,"type":19},40,"ESTIMATED","INTERVENTIONAL",[22],"NA","Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients. Livitol-17 consist of the 3 whole herbs and extract which has antioxidant, hepatoprotective as well as reno-protective properties. The aim of this trial is to study the efficacy of herbal supplement to improve the liver function of alcoholic liver disease subject.",[25],"Alcoholic Liver Disease","NOT_YET_RECRUITING","2018-04-19",{"date":29,"type":30},"2018-04-20","ACTUAL",{"date":32,"type":19},"2018-05-30",{"date":34,"type":19},"2028-11-30",{"name":36,"class":37},"Composite Interceptive Med Science","INDUSTRY",""]